Clinical trial
A Randomized, Double-Blind, Placebo-Controlled, Active Comparator, Multicenter Study to Validate Patient-Reported Outcome Instruments in Adult Subjects With Newly Diagnosed Nontuberculous Mycobacterial (NTM) Lung Infection Caused by Mycobacterium Avium Complex (MAC)
NCT04677543 is registered in ClinicalTrials.gov with Insmed Incorporated as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Double-Blind, Placebo-Controlled, Active Comparator, Multicenter Study to Validate Patient-Reported Outcome Instruments in Adult Subjects With Newly Diagnosed Nontuberculous Mycobacterial (NTM) Lung Infection Caused by Mycobacterium Avium Complex (MAC)
- Lead sponsor
- Insmed Incorporated
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- December 22, 2020
- Completion date
- May 9, 2023
- Enrollment
- 99 (actual)
- Sites
- 62
Conditions
As the registry lists them; a condition with its own page is linked.